BC
HCAT icon

Bridgefront Capital’s Health Catalyst HCAT Stock Holding History

Bridgefront Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,820
Closed -$212K – 482
2021
Q2 		$212K Sell
3,820
-653
-15% -$34.8K 0.08% 487
2021
Q1 		$209K Buy
+4,473
New +$217K 0.07% 570

Other funds holding HCAT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bridgefront Capital's HCAT Position: Q3 2021 in Review

Bridgefront Capital sold out of Health Catalyst (HCAT) in Q3 2021, closing a stake of 3,820 shares — an estimated $212K sold.

Bridgefront Capital first reported a position in HCAT in Q1 2021 and held it in 2 quarters. The position peaked at $212K in Q2 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q3 2021.

  • Bridgefront Capital reported no remaining Health Catalyst position as of Q3 2021 after selling out during the quarter.
  • Bridgefront Capital sold 3,820 Health Catalyst shares in Q3 2021, an estimated $212K.
  • Bridgefront Capital first reported a position in Health Catalyst in Q1 2021 and held it in 2 quarters.
  • Bridgefront Capital's Health Catalyst position peaked at $212K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2021.

Based on Bridgefront Capital's 13F filing for Q3 2021, filed 12 Nov 2021.